These emerging therapies, including Semaglutide , belong to a class of drugs called GLP-1 agents. Primarily developed for managing diabetes mellitus , they function by assisting the pancreas to secrete more insulin and reducing increased blood sugar levels. Beyond diabetes, their potential to support weight management has resulted to substantial… Read More